Therapeutic outcome of multifocal Langerhans cell histiocytosis in adults treated with the Special C regimen formulated by the Japan LCH Study Group-Reference-Cited by-同舟云学术

Therapeutic outcome of multifocal Langerhans cell histiocytosis in adults treated with the Special C regimen formulated by the Japan LCH Study Group

Published:2012-12-16 Issue:1 Volume:97 Page:103-108
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Morimoto Akira, ,Shimazaki Chihiro,Takahashi Satoshi,Yoshikawa Kouhei,Nishimura Ryosei,Wakita Hisashi,Kobayashi Yutaka,Kanegane Hirokazu,Tojo Arinobu,Imamura Toshihiko,Imashuku Shinsaku

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-012-1245-0.pdf

Reference16 articles.

1. Stockschlaeder M, Sucker C. Adult Langerhans cell histiocytosis. Eur J Haematol. 2006;76:363–8.

2. Stålemark H, Laurencikas E, Karis J, Gavhed D, Fadeel B, Henter JI. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 2008;51:76–81.

3. Allen CE, McClain KL. Langerhans cell histiocytosis: a review of past, current and future therapies. Drugs Today (Barc). 2007;43:627–43.

4. Tazi A. Adult pulmonary Langerhans’ cell histiocytosis. Eur Respir J. 2006;27:1272–85.

5. Aricò M, Girschikofsky M, Généreau T, Klersy C, McClain K, Grois N, et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer. 2003;39:2341–8.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trametinib for a child with refractory Rosai–Dorfman–Destombes disease harboring a novel somatic mutation in MAP2K1;International Journal of Hematology;2024-07-14

2. Comment on “Subcutaneous administration of cytarabine for pediatric patients with Langerhans cell histiocytosis decreases burden of patient travel and infusion center utilization”;Pediatric Blood & Cancer;2023-09-05

3. Clinical and prognostic features of Langerhans cell histiocytosis in adults;Cancer Science;2023-06-26

4. Management der Langerhans-Zell-Histiozytose bei erwachsenen Patienten;TumorDiagnostik & Therapie;2023-02

5. Severe myelosuppression involving HPV‐B19 infection and NUDT15 polymorphisms during therapy for LCH;Pediatrics International;2023-01